Disrupt CAD III Post-Approval Study (PAS)

NCT05021757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1212

Last updated 2024-02-01

Study results available
· View outcomes & findings →

Summary

The study design is a prospective, multicenter, observational, single-arm post-approval study using data collected in the National Cardiovascular Data Registry (NCDR®) CathPCI Registry®.

Conditions

Interventions

DEVICE

Shockwave C2 Coronary IVL

PCI procedure using a Shockwave C2 coronary IVL catheter

Sponsors & Collaborators

  • Shockwave Medical, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-10
Primary Completion
2022-03-31
Completion
2022-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05021757 on ClinicalTrials.gov